Paul  Kim net worth and biography

Paul Kim Biography and Net Worth

Paul Kim is the CFO at Fulgent Genetics, a role he has held since 2016. Fulgent is a leader in next generation sequencing, dedicated to creating affordable and flexible genetic testing.

Prior to joining Fulgent, Kim was the CFO for Cogent Systems, a manufacturer of automated fingerprint identification and facial recognition systems. The company was acquired by 3M in 2010. Cogent’s founder, Ming Hsieh, went on to found Fulgent in 2011, where Kim would later join him after a brief period of retirement. 

Before his tenures at Cogent and Fulgent, Kim served in executive finance positions for a variety of companies, including JNI Corporation, a storage area network technology company, Datafusion, a software development company, and Interlink Computer Sciences, an enterprise software company. He also worked as an audit manager at Coopers and Lybrand L.L.P.

Kim earned his bachelor’s degree in economics at the University of California, Berkeley, and he is a certified public accountant.

What is Paul Kim's net worth?

The estimated net worth of Paul Kim is at least $4.15 million as of December 4th, 2023. Mr. Kim owns 200,460 shares of Fulgent Genetics stock worth more than $4,153,531 as of April 16th. This net worth estimate does not reflect any other assets that Mr. Kim may own. Additionally, Mr. Kim receives an annual salary of $757,590.00 as CFO at Fulgent Genetics. Learn More about Paul Kim's net worth.

How old is Paul Kim?

Mr. Kim is currently 57 years old. There are 3 older executives and no younger executives at Fulgent Genetics. The oldest executive at Fulgent Genetics is Mr. Ming Hsieh, Chairman & CEO, who is 68 years old. Learn More on Paul Kim's age.

What is Paul Kim's salary?

As the CFO of Fulgent Genetics, Inc., Mr. Kim earns $757,590.00 per year. The highest earning executive at Fulgent Genetics is Mr. Ming Hsieh, Chairman & CEO, who commands a salary of $1,660,000.00 per year. Learn More on Paul Kim's salary.

How do I contact Paul Kim?

The corporate mailing address for Mr. Kim and other Fulgent Genetics executives is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Fulgent Genetics can also be reached via phone at (626) 350-0537 and via email at [email protected]. Learn More on Paul Kim's contact information.

Has Paul Kim been buying or selling shares of Fulgent Genetics?

Paul Kim has not been actively trading shares of Fulgent Genetics during the past quarter. Most recently, Paul Kim sold 1,437 shares of the business's stock in a transaction on Monday, December 4th. The shares were sold at an average price of $27.57, for a transaction totalling $39,618.09. Following the completion of the sale, the chief financial officer now directly owns 200,460 shares of the company's stock, valued at $5,526,682.20. Learn More on Paul Kim's trading history.

Who are Fulgent Genetics' active insiders?

Fulgent Genetics' insider roster includes John Bolger (Director), Hanlin Gao (Insider), Ming Hsieh (Chairman & CEO ), Paul Kim (CFO), and Jian Xie (COO). Learn More on Fulgent Genetics' active insiders.

Are insiders buying or selling shares of Fulgent Genetics?

During the last twelve months, insiders at the sold shares 14 times. They sold a total of 48,255 shares worth more than $1,448,973.19. The most recent insider tranaction occured on December, 11th when COO Jian Xie sold 22,000 shares worth more than $583,440.00. Insiders at Fulgent Genetics own 32.7% of the company. Learn More about insider trades at Fulgent Genetics.

Information on this page was last updated on 12/11/2023.

Paul Kim Insider Trading History at Fulgent Genetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2023Sell1,437$27.57$39,618.09200,460View SEC Filing Icon  
11/16/2023Sell1,307$27.25$35,615.75201,897View SEC Filing Icon  
8/28/2023Sell10,299$33.62$346,252.38215,553View SEC Filing Icon  
8/17/2023Sell1,798$33.88$60,916.24225,852View SEC Filing Icon  
6/2/2023Sell1,403$40.30$56,540.90228,890View SEC Filing Icon  
9/6/2022Sell662$41.39$27,400.18149,507View SEC Filing Icon  
6/2/2022Sell415$55.10$22,866.50153,162View SEC Filing Icon  
5/16/2022Sell1,191$53.38$63,575.58153,577View SEC Filing Icon  
3/3/2022Sell454$56.31$25,564.74View SEC Filing Icon  
12/2/2021Sell620$83.16$51,559.20View SEC Filing Icon  
11/18/2021Sell500$97.46$48,730.00View SEC Filing Icon  
11/16/2021Sell1,669$95.50$159,389.50View SEC Filing Icon  
9/2/2021Sell607$94.29$57,234.03135,176View SEC Filing Icon  
8/16/2021Sell1,682$95.12$159,991.84View SEC Filing Icon  
6/4/2021Sell789$74.26$58,591.14142,977View SEC Filing Icon  
6/2/2021Sell461$71.34$32,887.74142,977View SEC Filing Icon  
5/25/2021Sell10,358$72.94$755,512.52161,438View SEC Filing Icon  
5/18/2021Sell1,155$70.71$81,670.05171,796View SEC Filing Icon  
12/9/2020Sell10,662$51.60$550,159.20191,521View SEC Filing Icon  
12/2/2020Sell29,949$46.58$1,395,024.42231,502View SEC Filing Icon  
11/16/2020Sell100,000$46.17$4,617,000.00235,899View SEC Filing Icon  
9/2/2020Sell425$28.32$12,036.00335,899View SEC Filing Icon  
8/19/2020Sell136,643$42.12$5,755,403.16471,109View SEC Filing Icon  
8/17/2020Sell111,236$41.65$4,632,979.40471,109View SEC Filing Icon  
8/11/2020Sell1,396$42.06$58,715.76472,417View SEC Filing Icon  
6/2/2020Sell425$18.06$7,675.50433,813View SEC Filing Icon  
5/12/2020Sell1,421$16.31$23,176.51434,238View SEC Filing Icon  
8/12/2019Sell12,389$11.50$142,473.50412,250View SEC Filing Icon  
5/13/2019Sell1,404$5.50$7,722.00View SEC Filing Icon  
3/5/2019Sell1,165$4.67$5,440.55400,015View SEC Filing Icon  
11/13/2018Sell1,446$3.50$5,061.00View SEC Filing Icon  
8/13/2018Sell1,405$4.50$6,322.50382,626View SEC Filing Icon  
5/14/2018Sell1,370$3.72$5,096.40384,031View SEC Filing Icon  
3/8/2018Sell1,628$3.76$6,121.28385,401View SEC Filing Icon  
11/13/2017Sell1,573$3.22$5,065.06View SEC Filing Icon  
8/11/2017Sell6,134$5.71$35,025.14388,602View SEC Filing Icon  
See Full Table

Paul Kim Buying and Selling Activity at Fulgent Genetics

This chart shows Paul Kim's buying and selling at Fulgent Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fulgent Genetics Company Overview

Fulgent Genetics logo
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.
Read More

Today's Range

Now: $20.72
Low: $20.35
High: $20.96

50 Day Range

MA: $23.07
Low: $20.75
High: $26.17

2 Week Range

Now: $20.72
Low: $20.35
High: $44.09

Volume

157,558 shs

Average Volume

202,498 shs

Market Capitalization

$619.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43